NRA-PREGABALIN DIN 02479192
Health Canada record
| Active ingredient(s) | PREGABALIN 300 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N02BF02 PREGABALIN |
| Original market date | 23-Dec-2021 |
| Current status date | 23-Dec-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Nora Pharma Inc — licence 3-002506, currently licensed, last inspection rating C (2022-11-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PREGABALIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02394243 | APO-PREGABALIN | APOTEX INC | Capsule | PREGABALIN 50 MG | Marketed |
| 02268426 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 50 MG | Marketed |
| 02268434 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 75 MG | Marketed |
| 02268485 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 300 MG | Marketed |
| 02268450 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 150 MG | Marketed |
| 02268418 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 25 MG | Marketed |
| 02268477 | LYRICA | BGP PHARMA ULC | Capsule | PREGABALIN 225 MG | Marketed |
| 02359618 | PMS-PREGABALIN | PHARMASCIENCE INC | Capsule | PREGABALIN 50 MG | Marketed |
| 02359642 | PMS-PREGABALIN | PHARMASCIENCE INC | Capsule | PREGABALIN 300 MG | Marketed |
| 02359634 | PMS-PREGABALIN | PHARMASCIENCE INC | Capsule | PREGABALIN 150 MG | Marketed |
| 02359626 | PMS-PREGABALIN | PHARMASCIENCE INC | Capsule | PREGABALIN 75 MG | Marketed |
| 02359596 | PMS-PREGABALIN | PHARMASCIENCE INC | Capsule | PREGABALIN 25 MG | Marketed |
| 02377039 | RIVA-PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 25 MG | Marketed |
| 02377071 | RIVA-PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 300 MG | Marketed |
| 02377063 | RIVA-PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 150 MG | Marketed |
| 02377055 | RIVA-PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 75 MG | Marketed |
| 02377047 | RIVA-PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 50 MG | Marketed |
| 02390868 | SANDOZ PREGABALIN | SANDOZ CANADA INCORPORATED | Capsule | PREGABALIN 300 MG | Marketed |
| 02390817 | SANDOZ PREGABALIN | SANDOZ CANADA INCORPORATED | Capsule | PREGABALIN 25 MG | Marketed |
| 02390825 | SANDOZ PREGABALIN | SANDOZ CANADA INCORPORATED | Capsule | PREGABALIN 50 MG | Marketed |
| 02390833 | SANDOZ PREGABALIN | SANDOZ CANADA INCORPORATED | Capsule | PREGABALIN 75 MG | Marketed |
| 02390841 | SANDOZ PREGABALIN | SANDOZ CANADA INCORPORATED | Capsule | PREGABALIN 150 MG | Marketed |
| 02392844 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 150 MG | Marketed |
| 02392801 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 25 MG | Marketed |
| 02392828 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 50 MG | Marketed |
| 02392836 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 75 MG | Marketed |
| 02392852 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 225 MG | Marketed |
| 02392860 | TARO-PREGABALIN | SUN PHARMA CANADA INC | Capsule | PREGABALIN 300 MG | Marketed |
| 02361221 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 225 MG | Marketed |
| 02361205 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 150 MG | Marketed |
| 02361248 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 300 MG | Marketed |
| 02361175 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 50 MG | Marketed |
| 02361159 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 25 MG | Marketed |
| 02361183 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 75 MG | Marketed |
| 02394235 | APO-PREGABALIN | APOTEX INC | Capsule | PREGABALIN 25 MG | Dormant |
| 02360179 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 150 MG | Cancelled Post Market |
| 02360136 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 25 MG | Cancelled Post Market |
| 02360209 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 300 MG | Cancelled Post Market |
| 02360195 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 225 MG | Cancelled Post Market |
| 02360152 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 75 MG | Cancelled Post Market |
| 02360144 | GD-PREGABALIN | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | PREGABALIN 50 MG | Cancelled Post Market |
| 02268442 | LYRICA | UPJOHN CANADA ULC | Capsule | PREGABALIN 100 MG | Cancelled Pre Market |
| 02268469 | LYRICA | UPJOHN CANADA ULC | Capsule | PREGABALIN 200 MG | Cancelled Pre Market |
| 02382237 | MYLAN-PREGABALIN | MYLAN PHARMACEUTICALS ULC | Capsule | PREGABALIN 75 MG | Cancelled Post Market |
| 02382210 | MYLAN-PREGABALIN | MYLAN PHARMACEUTICALS ULC | Capsule | PREGABALIN 25 MG | Cancelled Post Market |
| 02382229 | MYLAN-PREGABALIN | MYLAN PHARMACEUTICALS ULC | Capsule | PREGABALIN 50 MG | Cancelled Post Market |
| 02382245 | MYLAN-PREGABALIN | MYLAN PHARMACEUTICALS ULC | Capsule | PREGABALIN 150 MG | Cancelled Post Market |
| 02382253 | MYLAN-PREGABALIN | MYLAN PHARMACEUTICALS ULC | Capsule | PREGABALIN 300 MG | Cancelled Post Market |
| 02376989 | PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 300 MG | Cancelled Pre Market |
| 02376970 | PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 150 MG | Cancelled Pre Market |
| 02376962 | PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 75 MG | Cancelled Pre Market |
| 02376954 | PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 50 MG | Cancelled Pre Market |
| 02376946 | PREGABALIN | LABORATOIRE RIVA INC. | Capsule | PREGABALIN 25 MG | Cancelled Pre Market |
| 02348837 | RATIO-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 150 MG | Cancelled Pre Market |
| 02348829 | RATIO-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 75 MG | Cancelled Pre Market |
| 02348810 | RATIO-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 50 MG | Cancelled Pre Market |
| 02348802 | RATIO-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 25 MG | Cancelled Pre Market |
| 02348845 | RATIO-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 300 MG | Cancelled Pre Market |
| 02361213 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 200 MG | Cancelled Pre Market |
| 02361191 | TEVA-PREGABALIN | TEVA CANADA LIMITED | Capsule | PREGABALIN 100 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21112 | 2018-07-20 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for PREGABALIN
27 valid EDQM Certificates of Suitability from 27 holders. 41 active FDA Drug Master Files.
Request a quote for NRA-PREGABALIN